However, depletion of FSP1 alone was sufficient to suppress tumor growth in a xenograft model of lung cancer [98], raising the possibility that treatment with only FSP1 inhibitors may have therapeutic value for certain cancers in vivo. This evidence concerns the gene AIFM2 and lung cancer.